| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/29/2002 | US20020119162 Synthetic vaccine agents |
| 08/29/2002 | US20020119161 Contacting Bordetella pertussis culture into with calcium phosphate gel for separating pertussis filamentous hemagglutinin (FHA), pertactin (PRN, 69K-OMP), pertussis fimbriae (FIM), and pertussis toxin |
| 08/29/2002 | US20020119160 Human T cell response to MHC-binding motif clusters |
| 08/29/2002 | US20020119159 Administering to a mucosal surface inducing antigen and mucosal binding component in unconjugated form for inducing sustained immunological tolerance in an individual to a target antigen |
| 08/29/2002 | US20020119158 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 08/29/2002 | US20020119157 For cancer therapy |
| 08/29/2002 | US20020119155 Protein-protein interactions in neurodegenerative diseases |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119151 CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/29/2002 | US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft |
| 08/29/2002 | US20020119148 ErbB4 antagonists |
| 08/29/2002 | US20020119128 Graft acceptance through manipulation of thymic regeneration |
| 08/29/2002 | US20020119127 Method and system for optimizing minigenes and peptides encoded thereby |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | US20020117170 Compositions and methods for the pulmonary delivery of aerosolized macromolecules |
| 08/29/2002 | CA2698079A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2443502A1 Use of mycobacterium .alpha. antigen to prevent or treat allergic diseases |
| 08/29/2002 | CA2440197A1 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | CA2439235A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 08/29/2002 | CA2438754A1 A cell therapy method for the treatment of tumors |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | CA2438322A1 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 08/29/2002 | CA2438245A1 Treatment involving dkk-1 or antagonists thereof |
| 08/29/2002 | CA2438012A1 H. influenzae antigen basb213 |
| 08/29/2002 | CA2437980A1 Methods of treating inflammation, particularly diabetes |
| 08/29/2002 | CA2437161A1 Anti-interferon-.alpha. antibodies |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2426659A1 Method for treatment of tumors using combination therapy |
| 08/28/2002 | EP1234584A1 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 08/28/2002 | EP1234580A1 Acellular Pertussis Vaccines and Methods of Preparation Thereof |
| 08/28/2002 | EP1234579A1 Acellular Pertussis Vaccines and Methods of Preparation Thereof |
| 08/28/2002 | EP1234574A1 Hair growth stimulant |
| 08/28/2002 | EP1234040A2 Hbv sequences |
| 08/28/2002 | EP1234039A2 85kDa NEISSERIAL ANTIGEN |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234036A2 Compositions and methods for the treatment of immune related diseases |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234024A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 08/28/2002 | EP1234023A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 08/28/2002 | EP1233984A2 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233982A2 Novel hcv non-structural polypeptide |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233974A2 37 staphylococcus aureus genes and polypeptides |
| 08/28/2002 | EP1233969A2 Mono- and disaccharide derivatives |
| 08/28/2002 | EP1233948A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 08/28/2002 | EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy |
| 08/28/2002 | EP1233785A1 "bonzo" chemokine receptor antibodies and ligands |
| 08/28/2002 | EP1233784A2 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 08/28/2002 | EP1233783A2 Hbv/hcv virus-like particle |
| 08/28/2002 | EP1233782A2 Eliciting hcv-specific antibodies |
| 08/28/2002 | EP1233781A1 Assays and therapies for latent viral infection |
| 08/28/2002 | EP1233780A1 Identification of sortase gene |
| 08/28/2002 | EP1233779A2 New uses of suppressive macrophage activation factors |
| 08/28/2002 | EP1233778A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 08/28/2002 | EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233773A1 Mixture of pomegranate seed oil and juice products |
| 08/28/2002 | EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY |
| 08/28/2002 | EP1077720B1 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
| 08/28/2002 | EP0988063B1 Process for reducing the concentration of viral and molecular pathogens in a biological material |
| 08/28/2002 | EP0941117B1 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids |
| 08/28/2002 | EP0912192B1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 08/28/2002 | EP0877626B1 Anti-cd18 antibodies for use against stroke |
| 08/28/2002 | EP0827591B1 Method for diagnosing chlamydia using an extracellular biological fluid |
| 08/28/2002 | EP0822828B1 Isolated 55 to 75 kda protein which binds to prion protein |
| 08/28/2002 | EP0808173B1 Product and method for preventing respiratory virus infection |
| 08/28/2002 | EP0804489B1 Antigenic preparation for treatment or prevention of helicobacter infection |
| 08/28/2002 | EP0794966B1 Humanized antibodies to cd38 |
| 08/28/2002 | EP0632814B1 High molecular weight surface proteins of non-typeable haemophilus |
| 08/28/2002 | CN1366061A Genetically engineered body of somatostatin gene vaccine (DNA vaccine) |
| 08/28/2002 | CN1366053A Infective molecule cloning of low virulent vaccine strain for horse infective anemia virus |
| 08/28/2002 | CN1366041A Broad spectrum infectious chicken blader disease virus vaccine |
| 08/28/2002 | CN1366040A Recombinant virus of human vascular endothelial growth inhibitor |
| 08/28/2002 | CN1089609C Method of recovering immunoglobulin from fractions produced during fractionation of human blood plasma |
| 08/28/2002 | CN1089608C Process for producing transfer factors resisting virus of respiratory tract |
| 08/28/2002 | CN1089607C Immunomodulatory complex for helicobacter bacteria |
| 08/28/2002 | CN1089606C Conjugate between modified superantigen and target-seeking compound and use of conjugate |
| 08/27/2002 | US6441144 Method for repairing dual virally inactivated immune globulin for intravenous administration |
| 08/27/2002 | US6441142 Detecting and quantifying allergens in foods; monoclonal antibody having antigen combining site with specificity for amino acid sequence arachis hypogaea ii; hybridoma cell lines which produce the antibodies |
| 08/27/2002 | US6441141 Synthetic peptides, antibodies against them and their use |
| 08/27/2002 | US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 08/27/2002 | US6440944 Methods of administering adenoviral vectors |
| 08/27/2002 | US6440743 Supplying immobilizated polynucleotides |
| 08/27/2002 | US6440735 Dendritic cell vaccine containing telomerase reverse transcriptase for the treament of cancer |
| 08/27/2002 | US6440718 Recombination to produce hepatitis a virus; gene expression |
| 08/27/2002 | US6440701 Transferrin receptor genes of Moraxella |
| 08/27/2002 | US6440696 E6 targeted protein (E6TP1) |
| 08/27/2002 | US6440690 Peptides for the activation of the immune system in humans and animals |
| 08/27/2002 | US6440679 Dermatomyositis-specific auto-antigen |
| 08/27/2002 | US6440663 Renal cancer associated antigens and uses therefor |
| 08/27/2002 | US6440656 Methods for the inhibition of respiratory syncytial virus transmission |
| 08/27/2002 | US6440426 Antigen-containing formulation and methods of use thereof |
| 08/27/2002 | US6440425 High molecular weight major outer membrane protein of moraxella |
| 08/27/2002 | US6440424 High molecular weight major outer membrane protein of moraxella |
| 08/27/2002 | US6440423 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440416 Primate antiidiotype antibody or fragment acting as immuno-genic functional mimic; preventive or therapeutic immune response against tumors, viruses, bacteria, rickettsia, mycoplasma, protozoa, fungi and multicellular parasites |
| 08/27/2002 | US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus |